Showing results (401-410 of 423) with videos related to

Sort By:
Pageof 43
Clinical Breast Cancer|April 3, 2026
Venous Thromboembolism After Pedicled TRAM Versus Free Flap Breast Reconstruction: A Propensity-Matched AnalysisSamuel A Knoedler, Julius M Wirtz, Giuseppe Sofo, et al.
BMC Medical Informatics and Decision Making|May 13, 2021
Head to head randomized trial of two decision aids for prostate cancerAngela Fagerlin, Margaret Holmes-Rovner, Timothy P Hofer, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 1, 2024
Development of Patient Safety Measures to Identify Inappropriate Diagnosis of Common InfectionsAndrea T White, Valerie M Vaughn, Lindsay A Petty, et al.
Health Affairs (Project Hope)|July 5, 2023
Adopting Weight-Based Dosing With Pharmacy-Level Stewardship Strategies Could Reduce Cancer Drug Spending By MillionsAlex K Bryant, Zoey Chopra, Donna M Edwards, et al.
Analytical Chemistry|November 17, 2022
Picosecond Infrared Laser Mass Spectrometry Identifies a Metabolite Array for 10 s Diagnosis of Select Skin Cancer Types: A Proof-of-Concept Feasibility StudyLauren Katz, Michael Woolman, Taira Kiyota, et al.
Drug Discovery Today|November 10, 2019
Nonclinical data supporting orphan medicinal product designations in the area of rare infectious diseasesMaria E Sheean, Eva Malikova, Dinah Duarte, et al.
JAMA Internal Medicine|September 14, 2020
Identifying Recommendations for Stopping or Scaling Back Unnecessary Routine Services in Primary CareEve A Kerr, Mandi L Klamerus, Adam A Markovitz, et al.
JAMA Internal Medicine|March 25, 2024
Inappropriate Diagnosis of Pneumonia Among Hospitalized AdultsAshwin B Gupta, Scott A Flanders, Lindsay A Petty, et al.
JCO Precision Oncology|June 3, 2026
Communication With Clinicians and Relatives About Cascade Genetic Testing in Cancer Patients With Germline Pathogenic VariantsAllison W Kurian, Paul Abrahamse, Allison Furgal, et al.
JCO Oncology Practice|June 18, 2026
Maintenance Pemetrexed/Pembrolizumab Versus Pembrolizumab in Non-Small Cell Lung Cancer: A Propensity Score-Weighted AnalysisGarth W Strohbehn, Molly C Tokaz, Daniel Sanghoon Shin, et al.
Pageof 43